These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8078374)

  • 1. Prevention of community-acquired pneumonia.
    Ortiz CR; La Force FM
    Med Clin North Am; 1994 Sep; 78(5):1173-83. PubMed ID: 8078374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for prevention of community-acquired pneumonia.
    Arunabh ; Niederman MS
    Semin Respir Infect; 1998 Mar; 13(1):68-78. PubMed ID: 9543477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated influenza vaccines for prevention of community-acquired pneumonia: the limits of using nonspecific outcomes in vaccine effectiveness studies.
    Ferdinands JM; Gargiullo P; Haber M; Moore M; Belongia EA; Shay DK
    Epidemiology; 2013 Jul; 24(4):530-7. PubMed ID: 23732734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
    Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
    Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness.
    Ansaldi F; De Florentiis D; Parodi V; Rappazzo E; Coppelli M; Martini M; Alicino C; Durando P; Icardi G
    J Prev Med Hyg; 2012 Jun; 53(2):94-7. PubMed ID: 23240167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Approach to Community-acquired Pneumonia.
    Cillóniz C; Rodríguez-Hurtado D; Nicolini A; Torres A
    J Thorac Imaging; 2018 Sep; 33(5):273-281. PubMed ID: 30005000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-acquired lower respiratory tract infections. Prevention and cost-control strategies.
    La Force FM
    Am J Med; 1985 Jun; 78(6B):52-7. PubMed ID: 4014288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines.
    Principi N; Esposito S
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28029140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
    Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
    Vaccine; 2007 Jun; 25(23):4631-40. PubMed ID: 17478015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age].
    Albrecht P; Antczak A; Hryniewicz W; Skoczyńska A; Radzikowski A; Kedziora-Kornatowska K; Bernatowska E; Stompór T; Grodzicki T; Gyrczuk E; Imiela J; Jedrzejczak W; Windak A
    Pol Merkur Lekarski; 2014 Feb; 36(212):79-87. PubMed ID: 24720101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower respiratory tract infections: prevention using vaccines.
    Whitney CG; Harper SA
    Infect Dis Clin North Am; 2004 Dec; 18(4):899-917. PubMed ID: 15555831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
    Esposito S; Principi N
    Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study.
    Koivula I; Stén M; Mäkelä PH
    Arch Intern Med; 1999 Jul; 159(14):1550-5. PubMed ID: 10421277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the Pneumonia Prevention Expert Group].
    Redondo E; Rivero-Calle I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Gil A; Molina J; Jimeno I; Ocaña D; Yuste JE; Martinón-Torres F;
    Semergen; 2018; 44(8):590-597. PubMed ID: 30318406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients.
    Polverino E; Cilloniz C; Menendez R; Gabarrus A; Rosales-Mayor E; Alcaraz V; Terraneo S; Puig de la Bella Casa J; Mensa J; Ferrer M; Torres A
    J Infect; 2015 Jul; 71(1):28-36. PubMed ID: 25882347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults.
    Suaya JA; Jiang Q; Scott DA; Gruber WC; Webber C; Schmoele-Thoma B; Hall-Murray CK; Jodar L; Isturiz RE
    Vaccine; 2018 Mar; 36(11):1477-1483. PubMed ID: 29429807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trends in the prevention and management of community-acquired pneumonia.
    Postma DF; van Werkhoven CH; Huijts SM; Bolkenbaas M; Oosterheert JJ; Bonten MJ
    Neth J Med; 2012 Oct; 70(8):337-48. PubMed ID: 23065981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Webber C; Patton M; Patterson S; Schmoele-Thoma B; Huijts SM; Bonten MJ;
    Vaccine; 2017 Mar; 35(9):1266-1272. PubMed ID: 28173960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands.
    van Deursen AMM; Schurink-Van't Klooster TM; Man WH; van de Kassteele J; van Gageldonk-Lafeber AB; Bruijning-Verhagen PCJL; de Melker HE; Sanders EAM; Knol MJ
    Vaccine; 2017 Dec; 35(51):7107-7113. PubMed ID: 29146381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.